Form 4: Biora Therapeutics Director Brian Kotzin Acquires Shares and Options

Director Brian L. Kotzin reports acquisition of Biora Therapeutics stock and options, signaling potential confidence in the company's future.

Summary

• On June 5, 2024, Brian L. Kotzin, a director of Biora Therapeutics, acquired 12,500 shares of common stock.
• These shares were acquired at a price of $0.
• Kotzin also acquired options to purchase 12,500 shares of common stock at an exercise price of $0.70.
• The options vest in full on the earlier of the first anniversary of the grant date or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
• Following these transactions, Kotzin directly owns 30,746 shares of Biora Therapeutics.
• Kotzin also owns options for 12,500 shares.

Sentiment

Score: 7

Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's future performance. However, the scale of the purchase is relatively small.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's prospects.
• The vesting schedule tied to continued service aligns the director's interests with the company's long-term success.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares and options by a director could positively influence shareholder sentiment.

Key Dates

Keywords

Biora Therapeutics, Director, Kotzin, Stock Options, Share Acquisition, Form 4, Beneficial Ownership